Vincent Aurentz
CIK 1657494 · Executive VP and CBO · last filed 2026-02-24
Vincent Aurentz is an Executive VP and CBO who has filed 28 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for IKT, was dated Feb 24, 2026. Across all open-market trades the lifetime net is −$5.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $852.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$852.7K
4
28
-$5.57M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IKT | Director | 510,596 | $1.67 | $852.7K | $0 | 4 | 2026-02-24 |
| Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Director | — | $59.98 | — | $0 | 5 | 2024-12-02 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | Executive VP and CBO | 0 | $99.99 | $0 | -$5.59M | 15 | 2022-03-11 |
| EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Chief Business Officer | 5,000 | — | — | $18.3K | 4 | 2016-05-31 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-24 | IKT | Disp (D) | −255,299 | $0 | EDGAR |
| 2025-07-02 | IKT | Grant (A) | — | $0 | EDGAR |
| 2025-07-02 | IKT | Grant (A) | — | $0 | EDGAR |
| 2025-02-25 | IKT | Grant (A) | — | $0 | EDGAR |
| 2024-12-02 | Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Disp (D) | — | $0 | EDGAR |
| 2024-05-24 | Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-26 | Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-31 | Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-11 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Mixed | −55,964 | $0 | EDGAR |
| 2022-01-05 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Grant (A) | +21,462 | $0 | EDGAR |